Skip to main content
Log in

Quality control

ERADication of STING limits inflammation

  • News & Views
  • Published:

From Nature Cell Biology

View current issue Submit your manuscript

The cGAS–STING cytosolic double-stranded-DNA-sensing pathway provides protection against infection but also contributes to inflammatory pathology and thus must be tightly regulated. In this issue, Jie et al. find that endoplasmic-reticulum-associated degradation of the adaptor STING by SEL1L–HRD1 controls steady-state STING levels to limit STING-driven inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: The pool of resting STING at the ER is limited by SEL1L–HRD1-mediated ERAD.

References

  1. Ji, Y. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-023-01138-4 (2023).

    Article  PubMed  Google Scholar 

  2. Ablasser, A. & Chen, Z. J. Science 363, eaat8657 (2019).

    Article  CAS  PubMed  Google Scholar 

  3. Gao, K. M., Marshak-Rothstein, A. & Fitzgerald, K. A. Curr. Opin. Immunol. 80, 102280 (2023).

    Article  CAS  PubMed  Google Scholar 

  4. Liu, D. et al. Cell Death Differ. 26, 1735–1749 (2019).

    Article  CAS  PubMed  Google Scholar 

  5. Jeltema, D., Abbott, K. & Yan, N. J. Exp. Med. 220, e20220990 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gentili, M. et al. Nat. Commun. 14, 611 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kuchitsu, Y. et al. Nat. Cell Biol. 25, 453–466 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Pokatayev, V. et al. Nat. Immunol. 21, 158–167 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gao, K. M., Motwani, M., Tedder, T., Marshak-Rothstein, A. & Fitzgerald, K. Proc. Natl Acad. Sci. USA 119, e2202327119 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wu, J., Dobbs, N., Yang, K. & Yan, N. Immunity 53, 115–126.e5 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gulen, M. F. et al. Nat. Commun. 8, 427 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Woo, S. R. et al. Immunity 41, 830–842 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jneid, B. et al. Sci. Immunol. 8, eabn6612 (2023).

    Article  CAS  PubMed  Google Scholar 

  14. Falahat, R. et al. Cancer Immunol. Res. 7, 1837–1848 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kitajima, S. et al. Cancer Discov. 9, 34–45 (2019).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katherine A. Fitzgerald.

Ethics declarations

Competing interests

K.F. is a scientific founder of Danger Bio, a Related Sciences company, and is a member of the scientific advisory board for Vesigen Therapeutics, NodThera, Janssen and Generation Bio. K.M.G. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, K.M., Fitzgerald, K.A. ERADication of STING limits inflammation. Nat Cell Biol 25, 635–636 (2023). https://doi.org/10.1038/s41556-023-01142-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41556-023-01142-8

  • Springer Nature Limited

This article is cited by

Navigation